Reconstruction of the distal tibia following resection of aggressive bone tumours using a custom-made megaprosthesis.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 28725124.
- Also identified by DOI 10.1016/j.jor.2017.06.003 and PMC identifier 5508224.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Largest, single-centre study of clinical and functional outcomes of patients who underwent endoprosthetic replacement (EPR) for aggressive distal tibial bone tumours. Retrospective observational study of eight patients was undertaken. Median follow-up was 77 months (range 13-276). Cumulative five and ten year survival was 63% and 42% respectively. Three patients developed either disease recurrence or metastases post-surgery. One patient developed deep infection requiring washout and suppressive antibiotics. No patients required revision surgery. The median MSTS score at last follow up was 66%. EPR of the distal tibia is a viable option and provides good function outcomes.
Anatomy
- tibia